1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)


SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

Cell lines tested with tanespimycin:bortezomib (250:1 mol/mol)

797 cell lines have been tested with this compound, using data from 1 dataset(s).
SNU-489 central nervous system CTRPv21
SIMA autonomic ganglia CTRPv21
SNU-245 biliary tract CTRPv21
HDQ-P1 breast CTRPv21
ALL-SIL haematopoietic and lymphoid tissue CTRPv21
253J urinary tract CTRPv21
RPMI-7951 skin CTRPv21
NMC-G1 central nervous system CTRPv21
HuCCT1 biliary tract CTRPv21
CAL-62 thyroid CTRPv21
Download CSV
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA NUP54 CTRPv2 AAC 0.2 6e-08
mRNA INTS7 CTRPv2 AAC 0.21 8e-08
mRNA LIN9 CTRPv2 AAC 0.2 1e-07
mRNA GTF3C6 CTRPv2 AAC 0.2 1e-07
mRNA GNPNAT1 CTRPv2 AAC 0.21 2e-07
mRNA LRP8 CTRPv2 AAC 0.19 4e-07
mRNA AC110615.1 CTRPv2 AAC 0.19 7e-07
mRNA PUS1 CTRPv2 AAC 0.18 1e-06
mRNA UCK2 CTRPv2 AAC 0.18 3e-06
mRNA WWC1 CTRPv2 AAC -0.21 4e-06
Download CSV